Page last updated: 2024-09-03

8-hydroxycarteolol and isoproterenol

8-hydroxycarteolol has been researched along with isoproterenol in 1 studies

Compound Research Comparison

Studies
(8-hydroxycarteolol)
Trials
(8-hydroxycarteolol)
Recent Studies (post-2010)
(8-hydroxycarteolol)
Studies
(isoproterenol)
Trials
(isoproterenol)
Recent Studies (post-2010) (isoproterenol)
61030,7808032,640

Protein Interaction Comparison

ProteinTaxonomy8-hydroxycarteolol (IC50)isoproterenol (IC50)
Beta-2 adrenergic receptorHomo sapiens (human)0.246
Beta-1 adrenergic receptorHomo sapiens (human)0.333
Beta-2 adrenergic receptorRattus norvegicus (Norway rat)0.2125
Polyunsaturated fatty acid lipoxygenase ALOX15Oryctolagus cuniculus (rabbit)1.77
Beta-1 adrenergic receptorRattus norvegicus (Norway rat)0.2125
Beta-3 adrenergic receptorRattus norvegicus (Norway rat)0.2125
Beta-2 adrenergic receptorCanis lupus familiaris (dog)0.6667

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Insel, PA; Jasper, JR; Michel, MC1

Other Studies

1 other study(ies) available for 8-hydroxycarteolol and isoproterenol

ArticleYear
The beta-adrenoceptor antagonist carteolol and its metabolite 8-hydroxycarteolol have different intrinsic sympathomimetic activities.
    British journal of clinical pharmacology, 1990, Volume: 30 Suppl 1

    Topics: Carteolol; Cyclic AMP; Humans; Isoproterenol; Lymphoma; Muscle, Smooth; Sympathomimetics; Tumor Cells, Cultured

1990